Industry experts from Marsh McLennan Agency (MMA) discuss how organizations can leverage innovative tools, such as biosimilar-first contracts, to effectively reduce pharmaceutical expenses without compromising care.



Related insights

Blogs

How to align cyber coverage with senior care communities

The healthcare industry remains one of the most targeted and costly sectors when it comes to cyber risk. Within healthcare, senior care organizations face a particularly complex challenge: they often manage sensitive resident data, rely on interconnected systems and third-party vendors, and operate in highly regulated environments where even ...

Flyers

The ultimate EPLI guide for Staffing firms

This Employment Practices Liability Insurance (EPLI) guide shares key insights for staffing firms, including common risks, operational blind spots, claims examples, coverage tips, and practical ways to improve defensibility.

Case Studies

Niles Township High School District 219 achieves $3.2M reduction in Rx costs

Learn how Niles Township High School District 219 achieved a $3.2M reduction in Rx costs.

More Insights